Role of Cell‐Cycle Proliferation Test, Triple Hit Phenotype, and TMPRSS2‐ERG Expression to Evaluate the Risk of Progression in Prostate Cancer Patients Under Active Surveillance

Documenti analoghi

• Histopathologic Features and Transcriptomic Signatures Do Not Solve the Issue of Magnetic Resonance Imaging‐Invisible Prostate Cancers: A Matched‐Pair Analysis
  di: Marco Oderda, et al.
  Pubblicazione: (2024)
• Use of Droplet Digital PCR for Consistent Detection of TMPRSS2:ERG Gene Fusion Transcripts Initiated In Vitro
  di: Megan H. Check, et al.
  Pubblicazione: (2025)
• ERG and PTEN Role on Active Surveillance for Low‐Risk Prostate Cancer in the Multiparametric MRI Era
  di: Marco Aurelio Watanabe Yorioka, et al.
  Pubblicazione: (2024)
• Downregulation of NONO Suppresses Proliferation, Migration, and Invasion in Metastatic Prostate Cancer
  di: Anna‐Lena Lemster, et al.
  Pubblicazione: (2025)
• Surveillance Versus Treatment for Favorable Intermediate‐Risk Prostate Cancer and Mortality‐Risk
  di: Mutlay Sayan, et al.
  Pubblicazione: (2026)